Document Detail


Resistance of B16 melanoma cells to CD47-induced negative regulation of motility as a result of aberrant N-glycosylation of SHPS-1.
MedLine Citation:
PMID:  14739297     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The adhesion receptor SHPS-1 activates the protein-tyrosine-phosphatase SHP-2 and thereby promotes integrin-mediated reorganization of the cytoskeleton. SHPS-1 also contributes to cell-cell communication through association with CD47. Although functional alteration of SHPS-1 is implicated in cellular transformation, the role of the CD47-SHPS-1 interaction in carcinogenesis has been unclear. A soluble SHPS-1 ligand (CD47-Fc) has now been shown to bind to Melan-a non-tumorigenic melanocytes but not to syngeneic B16F10 melanoma cells. Treatment of B16F10 cells with 1-deoxymannojirimycin, which prevents N-glycan processing, restored the ability of SHPS-1 derived from these cells to bind CD47-Fc in vitro, indicating that aberrant N-glycosylation of SHPS-1 impairs CD47 binding in B16F10 cells. CD47-Fc inhibited the migration of Melan-a cells but not that of B16F10 cells. However, a monoclonal antibody that reacts with SHPS-1 on both Melan-a and B16F10 cells inhibited the migration of both cell types similarly. CD47 binding induced proteasome-mediated degradation of SHPS-1 in a tyrosine phosphorylation-independent manner. Furthermore, overexpression of SHPS-1 reduced the level of tyrosine phosphorylation of focal adhesion kinase, and this effect was reversed by CD47 binding. These results suggest that CD47 binds to and thereby down-regulates SHPS-1 on adjacent cells, resulting in inhibition of cell motility. Resistance to this inhibitory mechanism may contribute to the highly metastatic potential of B16 melanoma.
Authors:
Takeshi Ogura; Tetsuya Noguchi; Reiko Murai-Takebe; Tetsuya Hosooka; Nakayuki Honma; Masato Kasuga
Related Documents :
9821077 - 'tubular' epithelioid cell nevus: a new variant of spitz's nevus.
2447807 - Signet-ring cell melanoma. a rare morphologic variant of malignant melanoma.
21252997 - Dedifferentiation, transdifferentiation and reprogramming: three routes to regeneration.
6641917 - Population dynamics of arterial cells during atherogenesis. xiii. mitogenic and cytotox...
9199357 - Glial development in the drosophila cns requires concomitant activation of glial and re...
8599577 - Suppression of the metastatic phenotype of a mouse skin carcinoma cell line independent...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2004-01-21
Journal Detail:
Title:  The Journal of biological chemistry     Volume:  279     ISSN:  0021-9258     ISO Abbreviation:  J. Biol. Chem.     Publication Date:  2004 Apr 
Date Detail:
Created Date:  2004-03-29     Completed Date:  2004-05-11     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  2985121R     Medline TA:  J Biol Chem     Country:  United States    
Other Details:
Languages:  eng     Pagination:  13711-20     Citation Subset:  IM    
Affiliation:
Department of Clinical Molecular Medicine, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Antigens, CD / genetics,  metabolism*
Antigens, CD47
Antigens, Differentiation*
Carrier Proteins / genetics,  metabolism*
Cell Communication / physiology
Cell Line, Tumor
Cell Movement / physiology*
Cysteine Endopeptidases / metabolism
Down-Regulation / physiology
Focal Adhesion Kinase 1
Focal Adhesion Protein-Tyrosine Kinases
Glycosylation
Ligands
Macrophages / cytology,  metabolism
Melanocytes / cytology,  metabolism
Melanoma, Experimental*
Membrane Glycoproteins / metabolism*
Mice
Multienzyme Complexes / metabolism
Neural Cell Adhesion Molecule L1 / metabolism*
Phosphorylation
Proteasome Endopeptidase Complex
Protein-Tyrosine Kinases / metabolism
Receptors, Immunologic / metabolism*
Skin Neoplasms*
Solubility
Tyrosine / metabolism
Chemical
Reg. No./Substance:
0/Antigens, CD; 0/Antigens, CD47; 0/Antigens, Differentiation; 0/Carrier Proteins; 0/Cd47 protein, mouse; 0/Ligands; 0/Membrane Glycoproteins; 0/Multienzyme Complexes; 0/Neural Cell Adhesion Molecule L1; 0/Ptpns1 protein, mouse; 0/Receptors, Immunologic; 55520-40-6/Tyrosine; EC 2.7.1.112/Ptk2 protein, mouse; EC 2.7.10.1/Focal Adhesion Kinase 1; EC 2.7.10.1/Protein-Tyrosine Kinases; EC 2.7.10.2/Focal Adhesion Protein-Tyrosine Kinases; EC 3.4.22.-/Cysteine Endopeptidases; EC 3.4.25.1/Proteasome Endopeptidase Complex

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Inactivation of the 25-hydroxyvitamin D 1alpha-hydroxylase and vitamin D receptor demonstrates indep...
Next Document:  A cleaved form of MAGE-A4 binds to Miz-1 and induces apoptosis in human cells.